Daily Text Message Symptom Checks for People With Multiple Myeloma or AL Amyloidosis
Looks at daily text message symptom checks in adults treated for these conditions.
Plain-language title generated from the registry record
Registry title: SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Key facts
- Where
- Rochester, United StatesSee the site
Where in United States
- Mayo Clinic in RochesterRochester, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT07850284
- Record updated
- 30 September 2026
- Original description
This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.Read full original descriptionShow less
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.
Inclusion: Age >= 18 years; Diagnosis of MM or AL based on IMWG diagnostic criteria; Planned to start a new treatment within 14 days (+/-7 days); Able to provide written informed consent.
Exclusion: Not able to give informed consent.